Vergleich

H-89 Europäischer Partner

ArtNr HY-15979-100mg
Hersteller MedChem Express
CAS-Nr. 127243-85-0
Menge 100 mg
Quantity options 100 mg 10 mM/1 mL 10 mg 1 ea 50 mg 5 mg
Kategorie
Typ Inhibitors
Specific against other
Purity 99.96
Citations [1]Chijiwa T, et al. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem. 1990 Mar 25;265(9):5267-72.|[2]Blazev R, et al. Effects of the PKA inhibitor H-89 on excitation-contraction coupling in skinned and intact skeletal muscle fibres. J Muscle Res Cell Motil. 2001;22(3):277-86.|[3]Hosseini-Zare MS, et al. Effects of pentoxifylline and H-89 on epileptogenic activity of bucladesine in pentylenetetrazol-treated mice. Eur J Pharmacol. 2011 Nov 30;670(2-3):464-70.
ACS Nano. 2025 Jul 1;19(25):22755-22766.
Acta Biochim Biophys Sin (Shanghai). 2023 Nov 15;55(12):1855-1863.
Adv Sci (Weinh). 2024 Jul 1:e2403640.
Adv Sci (Weinh). 2025 Feb 7:e2413324.
Am J Physiol Cell Physiol. 2024 Jun 1;326(6):C1683-C1696.
Andrology. 2025 Jul 2.
Anim Nutr. 2022 Dec 31:13:185-196.
Ann Rheum Dis. 2025 Oct 28:S0003-4967(25)04428-0.
Aquac Rep. 2024 Jun, 36, 102110.
Aquac Res. 2020;00:1-10.
Arch Biochem Biophys. 2020 Jul 15;687:108375.
Biol Pharm Bull. 2024;47(6):1113-1118.
Biol Reprod. 2025 Sep 18:ioaf213.
Biomaterials. 2022 Dec:291:121902.
Biomed Pharmacother. 2022 Apr:148:112728.
bioRxiv. 2025 May 12.
bioRxiv. 2025 Nov 28.
BMC Biol. 2024 May 3;22(1):104.
BMC Genomics. 2024 Apr 3;25(1):337.
BMC Pharmacol Toxicol. 2023 Nov 20;24(1):63.
Bone. 2020 Jun;135:115326.
Brain Behav Immun. 2024 Jan:115:667-679.
Brain Behav Immun. 2024 Jul:119:36-50.
Cancer Cell Int. 2019 Sep 23;19:241.
Cell Commun Signal. 2021 Oct 11;19(1):103.
Cell Commun Signal. 2024 Jul 25;22(1):375.
Cell Death Dis. 2024 Sep 30;15(9):699.
Cell Death Dis. 2025 Aug 7;16(1):595.
Cell Death Discov. 2025 Apr 6;11(1):148.
Cell Metab. 2021 Mar 2;33(3):565-580.e7.
Cell Metab. 2021 Oct 5;33(10):2021-2039.e8.
Cell Mol Immunol. 2023 Feb;20(2):175-188.
Cell Rep. 2021 Sep 21;36(12):109726.
Cell Rep. 2022 Oct 18;41(3):111498.
Cells. 2023 Apr 6;12(7):1098.
Chem Biol Interact. 2024 Sep 2:111224.
Chem Sci. 2019 Dec 6;11(4):1132-1139.
Clin Transl Med. 2021 Jan;11(1):e266.
CNS Neurosci Ther. 2024 May;30(5):e14742.
Ecotoxicol Environ Saf. 2021 May:214:112005.
Endocrinology. 2023 Mar 13;164(5):bqad042.
Evid Based Complement Alternat Med. 2020 Dec 15:2020:8514926.
Fitoterapia. 2022 Nov:163:105336.
Free Radic Biol Med. 2024 May 31:222:72-84.
Front Oncol. 2021 Oct 6;11:738300.
Front Physiol. 2021 Oct 28;12:770430.
Front Physiol. 2022 Jan 5:12:736920.
Genes Dis. 2020 Nov 21;8(6):867-881.
Heart Surg Forum. 2024 Mar 17.
Heliyon. 2024 Sep 19;10(19):e37958.
Infect Immun. 2018 Dec 19;87(1). pii: e00508-1
Int Immunopharmacol. 2025 May 17:158:114885.
Int J Biol Macromol. 2025 Apr 26:143548.
Int J Biol Sci. 2024 Aug 19;20(11):4476-4495.
Int J Mol Sci. 2018 Oct 7;19(10). pii: E3053.
Int J Mol Sci. 2022 Dec 24;24(1):320.
Int J Mol Sci. 2022 Oct 20;23(20):12595.
Int J Mol Sci. 2023 Jan 16;24(2):1771.
Invest Ophthalmol Vis Sci. 2025 Jul 1;66(9):68.
iScience. 2021 Jul 8;24(8):102820.
iScience. 2025 Jan 21;28(2):111856.
J Adv Res. 2025 Apr 22:S2090-1232(25)00278-4.
J Agric Food Chem. 2023 Nov 1;71(43):16148-16159.
J Appl Biol Chem. 2025;68:26, 204‒211.
J Biol Chem. 2021 Jan-Jun:296:100644.
J Bone Miner Metab. 2021 Sep;39(5):748-756.
J Cell Mol Med. 2024 Apr;28(8):e18303.
J Exp Clin Cancer Res. 2021 Apr 8;40(1):122.
J Exp Clin Cancer Res. 2024 Apr 4;43(1):105.
J Gastroenterol Hepatol. 2025 Jul 31.
J Int Med Res. 2021 Mar;49(3):300060521999527.
J Integr Agric. 2023 Feb 24.
J Mater Sci Technol. 2023 Jun 30.
J Med Chem. 2025 Nov 13;68(21):23277-23299.
J Neuroinflammation. 2025 Oct 14;22(1):233.
J Neurophysiol. 2024 Jan 1;131(1):64-74.
J Neurosci. 2016 Oct 12;36(41):10560-10573.
J Orthop Surg Res. 2023 Nov 8;18(1):849.
J Periodontol. 2019 Sep;90(9):1002-1013.
Korean J Pain. 2023 Jul 1;36(3):335-346.
Life Sci. 2025 May 15:369:123553.
Microbiol Res. 2024 May 24:285:127779.
Mol Brain. 2021 Jul 19;14(1):116.
Mol Cell. 2023 Apr 6;83(7):1093-1108.e8.
Mol Neurobiol. 2025 Jan;62(1):366-385.
Mol Reprod Dev. 2022 May;89(5-6):256-268.
Nat Commun. 2022 Nov 4;13(1):6648.
Nat Commun. 2025 Jul 28;16(1):6942.
Neuro Oncol. 2024 Jan 5;26(1):137-152.
Neurogastroenterol Motil. 2020 Oct;32(10):1514-1528.
NPJ Biofilms Microbiomes. 2023 Feb 8;9(1):8.
Nutr Diabetes. 2024 Jul 23;14(1):56.
Nutrients. 2020 Jan 26;12(2):329.
Phytomedicine. 2025 Mar:138:156375.
Proteome Sci. 2023 Oct 11;21(1):16.
Psychoneuroendocrinology. 2020 Jul;117:104680.
Res Sq. 2024 Jul 15.
Res Sq. 2024 May 23.
Res Sq. 2025 Apr 08.
Research Square Preprint. 2020 Oct.
Research Square Preprint. 2023 Sep 13.
Sci Rep. 2025 Oct 16;15(1):36270.
Sci Signal. 2020 Nov 24;13(659):eaax0273.
Signal Transduct Target Ther. 2023 Aug 9;8(1):290.
Small Methods. 2025 Mar;9(3):e2401144.
SSRN. 2025 Apr 10.
SSRN. 2025 Mar 24.
Stem Cell Res Ther. 2020 Jan 3;11(1):2.
Theranostics. 2021 Mar 24;11(12):5650-5674.
Toxicol Lett. 2022 Apr 15:359:84-95.
Transl Psychiatry. 2025 Oct 6;15(1):366.
Acta Pharm Sin B. 2024 Mar;14(3):1222-1240.
Adv Sci (Weinh). 2021 Dec;8(24):e2100808.
Adv Sci (Weinh). 2025 Apr 28:e2409837.
Adv Sci (Weinh). 2025 Sep 26:e02395.
Aging (Albany NY). 2018 Jul 24;10(7):1722-1744.
Aging (Albany NY). 2020 Jun 9;12(11):10951-10968.
Aging Cell. 2018 Jun;17(3):e12754.
AUTHOREA. 2025 May 27.
Biochem Biophys Res Commun. 2024 Apr 9:703:149689.
Biol Trace Elem Res. 2021 Jul;199(7):2687-2694.
bioRxiv. 2024 Feb 8.
bioRxiv. 2024 Oct 2:2024.09.30.615856.
bioRxiv. 2024 Oct 22:2024.10.18.619152.
Cell Commun Signal. 2022 Apr 12;20(1):52.
Cell Death Dis. 2025 Jan 20;16(1):31.
Elife. 2023 Jan 16:12:e81438.
Environ Health (Wash). 2024 Aug 16;2(11):776-785.
Eur J Neurosci. 2025 Jul;62(2):e70198.
Eur J Pharmacol. 2024 Nov 6:985:177106.
Exp Cell Res. 2021 Feb 15;399(2):112482.
Exp Ther Med. 2022 Apr;23(4):248.
FASEB J. 2020 Oct;34(10):13376-13395.
Front Pharmacol. 2018 Apr 12:9:362.
Harvard Medical School LINCS LIBRARY
IJMPNP. 2019,5(1): 8-15.
Int Immunopharmacol. 2024 Feb 15:128:111490.
Int J Biol Sci. 2023 Apr 2;19(7):2006-2019.
J Agric Food Chem. 2025 Aug 13;73(32):20235-20253.
J Bone Miner Res. 2021 Aug;36(8):1605-1620.
J Cell Mol Med. 2020 Apr;24(8):4736-4747.
J Funct Foods. 2023 Dec, 111, 105902.
J Funct Foods. 2025 Aug.
Life Sci. 2022 Aug 15:303:120676.
Nat Commun. 2023 May 31;14(1):3159.
Nat Commun. 2025 Jul 1;16(1):5425.
Nat Metab. 2024 Apr;6(4):708-723.
PeerJ. 2022 Oct 25:10:e14192.
Peptides. 2022 Aug:154:170824.
Phytomedicine. 2025 Dec:149:157494.
Phytother Res. 2023 Apr;37(4):1330-1345.
Prog Neurobiol. 2021 Jul:202:102041.
Purinergic Signal. 2022 Sep;18(3):317-343.
Reprod Sci. 2023 Apr;30(4):1281-1290.
Research Square Preprint. 2024 Dec 04.
Sci Total Environ. 2022 Oct 10:842:156854.
Stem Cell Res Ther. 2020 May 19;11(1):182.
Theranostics. 2021 Jan 1;11(6):2612-2633.
Vet Microbiol. 2021 May:256:109061.
Smiles O=S(C1=CC=CC2=C1C=CN=C2)(NCCNC/C=C/C3=CC=C(Br)C=C3)=O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 127243-85-0
Versandbedingung Raumtemperatur
Lieferbar
Manufacturer - Type
Reference compound
Manufacturer - Applications
Neuroscience-Neuromodulation
Manufacturer - Category
Reference compound / Active compounds
Manufacturer - Targets
Autophagy; PKA
Manufacturer - HS Code
H302, H312, H315, H319, H332, H335
Shipping Temperature
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Molecular Weight
446.36
Product Description
H-89 is a potent and selective inhibitor of cyclic AMP-dependent protein kinase (protein kinase A) with IC50 of 48 nM and has weak inhibition on PKG, PKC, Casein Kinase, and others kinases.
Manufacturer - Research Area
Neurological Disease
Solubility
DMSO : 100 mg/mL (ultrasonic)
Manufacturer - Pathway
Autophagy; Stem Cell/Wnt; TGF-beta/Smad
Clinical information
No Development Reported
UNSPSC Code
12352005
Precautionary
H302, H312, H315, H319, H332, H335

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 100 mg
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?